3 CEs



See Provider Info

Webinar Description

Cannabis ranks as the second most commonly used substance nationwide, trailing only tobacco and alcohol (NIH). Approximately 16 million Americans report regular cannabis use (NIH), with the majority initiating use during their teenage years (NIH). The broad legalization of marijuana has brought about challenges, with a failure to address increased toxicity and adverse effects on early teens and young adults. Notably, there has been a marked rise in cannabis-related hospitalizations for anxiety, paranoia, and psychosis, causing significant concern.

Research indicates that cannabis use accelerates the onset of schizophrenia by three years. Furthermore, a worrisome association exists between cannabis and various psychotic disorders, including schizoaffective disorder, schizophreniform disorder, brief psychotic disorder, delusional disorder, and substance-induced psychotic disorder. Cannabis is also linked to the onset of bipolar disorder with psychotic features and an increase in the manifestation of manic symptoms.

Like this webinar? Click here to view packages that contain this webinar.

Browse Other Webinars